Modulation of the IGF system and proliferation in human endometrial stromal cells by metformin: a dose-dependent effect (Q41425232)

30 September 2017

Modulation of the IGF system and proliferation in human endometrial stromal cells by metformin: a dose-dependent effect (English)

1 reference

30 September 2017

1 reference

6

1 reference

30 September 2017

Marie-Luise Jung

1

1 reference

30 September 2017

Tobias Renke

2

1 reference

30 September 2017

Oliver Nowak

3

1 reference

30 September 2017

Julia Jauckus

4

1 reference

30 September 2017

Markus Zorn

5

1 reference

30 September 2017

Thomas Strowitzki

7

1 reference

30 September 2017

Ariane Germeyer

8

1 reference

30 September 2017

17 February 2015

1 reference

Archives of Gynecology and Obstetrics

30 September 2017

1 reference

30 September 2017

292

1 reference

30 September 2017

465-472

1 reference

30 September 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s00404-015-3650-0

30 September 2017

0 references

cites work

Insulin resistance and metformin in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3650-0

Polycystic ovary syndrome - from gynaecological curiosity to multisystem endocrinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3650-0

Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3650-0

A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3650-0

A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3650-0

Metformin has direct effects on human ovarian steroidogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3650-0

Reverse of progestin-resistant atypical endometrial hyperplasia by metformin and oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3650-0

Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3650-0

Insulin-like growth factors in endometrial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3650-0

Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3650-0

IGFBP2 and IGFBP3 protein expressions in human breast cancer: association with hormonal factors and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3650-0

Structure of the receptor for insulin-like growth factor II: the puzzle amplified

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3650-0

Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3650-0

Dose-dependent insulin regulation of insulin-like growth factor binding protein-1 in human endometrial stromal cells is mediated by distinct signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3650-0

Metformin modulates IL-8, IL-1β, ICAM and IGFBP-1 expression in human endometrial stromal cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3650-0

Metformin alters insulin signaling and viability of human granulosa cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3650-0

Effects of testosterone and metformin on glucose metabolism in endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3650-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3650-0

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3650-0

Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3650-0

Relationship between abnormal glucose tolerance test and history of previous recurrent miscarriages, and beneficial effect of metformin in these patients: a prospective clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3650-0

The comparison of insulin resistance frequency in patients with recurrent early pregnancy loss to normal individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3650-0

Increased insulin-like growth factor-I levels in women with polycystic ovary syndrome, and beneficial effects of metformin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3650-0

Interleukin-11 inhibits expression of insulin-like growth factor binding protein-5 mRNA in decidualizing human endometrial stromal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3650-0

Metformin inhibits melanoma development through autophagy and apoptosis mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3650-0

Signalling pathways involved in antiproliferative effects of IGFBP-3: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3650-0

Insulin-like growth factor-binding protein-5 (IGFBP-5) inhibits TNF-α-induced NF-κB activity by binding to TNFR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3650-0

Signaling pathways involved in human vascular smooth muscle cell proliferation and matrix metalloproteinase-2 expression induced by leptin: inhibitory effect of metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3650-0

Chemopreventive effects of metformin on obesity-associated endometrial proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3650-0

Metformin and cancer: new applications for an old drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3650-0

Life-style and metformin for the prevention of endometrial pathology in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-015-3650-0

10.1007/S00404-015-3650-0

21 January 2018

Identifiers

DOI

1 reference

release_ugpfw523vjgrvovkadwn72p3pe

30 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ugpfw523vjgrvovkadwn72p3pe

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference